Search form
Search
contact us
Navigation
home
boards
job center
job ratings
cp wire
device news
pharmagather
catering
advertise
Legal Help
login/register
You are here
Home
»
companies
» cabazitaxel
cabazitaxel
Sanofi Says Cabazitaxel Improved Prostate Cancer Survival by 28%
Sanofi Says Cabazitaxel Improved Prostate Cancer Survival by 28%
Bloomberg
prostate cancer
cabazitaxel
Sanofi
Flag link:
Sanofi's Cancer Drug May Set New Standard
Sanofi's Cancer Drug May Set New Standard
TheStreet.com
Sanofi
cabazitaxel
Medivation
JNJ
Provenge
Dendreon
prostate cancer
Flag link: